Quest Laboratories IPO Peer Comparison
Quest Laboratories Limited peer comparison with similar listed entities. (As on March 31, 2023)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|
| Quest Laboratories Limited | 4.66 | 4.66 | 13.93 | | 33.47 | | |
| Beta Drugs Limited | 19.57 | 19.57 | 100.12 | 66.43 | 19.55 | 12.98 | Standalone |
| Alpa Laboratories Ltd. | 5.90 | 5.90 | 68.69 | 15.92 | 8.59 | 1.37 | Standalone |
| Zenith Drugs Limited | 4.29 | 4.29 | 14.37 | 14.69 | 29.88 | 4.38 | Consolidated |
Notes:
- The figures for the company are based on Restated Financial Statements for the year ended March 31, 2023 after considering the bonus issue.
- The figures for the Peer Group are based on the Standalone Financial Statements filed for the financial year ended March 31, 2023. (Expect for Zenith Drugs Limited Consolidated Financial Statements are considered for period ended March 31, 2023)
- P/E Ratio has been computed based on their respective closing market price on May 06, 2024 as divided by the Basic EPS as on March 31, 2023.
